Few companies have managed to blend innovation, consistency, and scale as effectively as Novo Nordisk. Founded over a century ago, this Danish pharmaceutical powerhouse has evolved from a pioneer in insulin therapy to a global leader in diabetes and obesity management. Its journey mirrors the broader shifts in global healthcare - from chronic care management to lifestyle-driven metabolic diseases - and today, the company finds itself at the heart of one of the most powerful medical and market narratives in the world: